C.G.G. Link

709 citations

14 papers · 585 indexed · h-index 8

Impact in

Psychiatry and Mental health top 2%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
- Electroconvulsive Therapy Studies
- Epilepsy research and treatment
Biological Psychiatry top 10%

Papers in

Psychiatry and Mental health 9
- Schizophrenia research and treatment 7
- Bipolar Disorder and Treatment 4
- Electroconvulsive Therapy Studies 3
Biological Psychiatry 1

Co-authors: J. Peuskens Barbara Kowalcyk David Copolov David J. King Lisa A. Arvanitis Barry D. Zussman B.G. Miller Mark B. Hamner
Journals: European Neuropsychopharmacology (3 papers)Acta Psychiatrica Scandinavica (3 papers)Biological Psychiatry (2 papers)The British Journal of Psychiatry (1 paper)European Psychiatry (1 paper)
Partner nations: United Kingdom United States Australia

In The Last Decade

C.G.G. Link

14 papers receiving 539 citations

Peers

Countries citing papers authored by C.G.G. Link

Since Specialization

Citations

This map shows the geographic impact of C.G.G. Link's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.G.G. Link with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.G.G. Link more than expected).

Fields of papers citing papers by C.G.G. Link

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.G.G. Link. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.G.G. Link. The network helps show where C.G.G. Link may publish in the future.

Co-authors

The 17 scholars most cited alongside C.G.G. Link, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C.G.G. Link Line = papers co-authored together C.G.G. Link links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work
1	A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, ‘Seroquel’) and haloperidol in schizophrenia Psychological Medicine ·David Copolov, C.G.G. Link, Barbara Kowalcyk	2000	120
2	A comparison of bd and tid dose regimens of quetiapine (Seroquel) in the treatment of schizophrenia Psychopharmacology ·David J. King, C.G.G. Link, Barbara Kowalcyk	1998	61
3	A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia Acta Psychiatrica Scandinavica ·J. Peuskens, C.G.G. Link	1997	205
4	‘Seroquel’™ (ICI 204,636) EPS and prolactin: Comparison with haloperidol European Psychiatry ·C.G.G. Link, Noureddin elmsaouri, Melanie Massote	1996	4
5	ICI 204, 636: A New Atypical Antipsychotic Drug The British Journal of Psychiatry ·Steven R. Hirsch, C.G.G. Link, Jeffrey M. Goldstein, Lisa A. Arvanitis	1996	36
6	Seroquel (ICI 204636): An atypical antipsychotic — Results from phase III European Neuropsychopharmacology ·David J. King, C.G.G. Link	1996	3
7	Switching from a conventional antipsychotic (haloperidol) to an atypical antipsychotic (‘Seroquel’ ’ ICI 204,636) European Neuropsychopharmacology ·Jonathan S.E. Hellewell, Breckenridge Fj, C.G.G. Link	1996	4
8	Plasma prolactin in schizophrenia subjects treated with Seroquel (ICI 204,636). PubMed ·Mark B. Hamner, Lisa A. Arvanitis, B.G. Miller, C.G.G. Link, Walter W. Hong	1996	47
9	Seroquel (ICI 204, 636): A novel, atypical antipsychotic Biological Psychiatry ·Richard L. Borison, Lisa A. Arvanitis, B.G. Miller, C.G.G. Link, Andrew Sell	1995	3
10	The effects of Seroquel (ICI 204.636) on plasma prolactin in patients with schizophrenia Biological Psychiatry ·Mark B. Hamner, Lisa A. Arvanitis, B.G. Miller, C.G.G. Link, Wei Hong	1995	2
11	A multicentre, double-blind, controlled comparison of SeroquelTM and chlorpromazine in the treatment of hospitalised patients with acute exacerbation of subchronic and chronic schizophrenia European Neuropsychopharmacology ·C.G.G. Link, Alex K. Smith, B.G. Miller, James Ryan	1994	8
12	An overview of studies comparing the efficacy, safety, and tolerability of paroxetine and clomipramine Nordic Journal of Psychiatry ·C.G.G. Link, G. C. Dunbar	1992	5
13	Remoxipride versus thioridazine in elderly psychotic patients Acta Psychiatrica Scandinavica ·Lucille King, C.G.G. Link	1990	21
14	Paroxetine plasma levels: lack of correlation with efficacy or adverse events Acta Psychiatrica Scandinavica ·Ane Kristiansen, 清雄佐藤, Barry D. Zussman, C.G.G. Link	1989	66

About C.G.G. Link

C.G.G. Link is a scholar working on Psychiatry and Mental health, Biological Psychiatry, Geriatrics and Gerontology, Endocrinology, Diabetes and Metabolism and Pharmacology, having authored 14 papers that have together received 585 indexed citations. Recurring topics across this work include Schizophrenia research and treatment (7 papers), Bipolar Disorder and Treatment (4 papers), Pituitary Gland Disorders and Treatments (3 papers), Treatment of Major Depression (3 papers), Electroconvulsive Therapy Studies (3 papers), Diet and metabolism studies (3 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 papers) and Alcoholism and Thiamine Deficiency (1 paper). The work is most often cited by research in Psychiatry and Mental health (500 citations), Biological Psychiatry (37 citations), Pharmacology (143 citations), Philosophy (80 citations) and Cellular and Molecular Neuroscience (75 citations). C.G.G. Link has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include J. Peuskens, Barbara Kowalcyk, David Copolov, David J. King, Lisa A. Arvanitis, Barry D. Zussman, B.G. Miller, Mark B. Hamner, Walter W. Hong and Jeffrey M. Goldstein. Their work appears in journals such as European Neuropsychopharmacology, Acta Psychiatrica Scandinavica, Biological Psychiatry, The British Journal of Psychiatry and European Psychiatry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact